参考文献/References:
[1] Lee JW, Wen PY, Hurwitz S, et al. Morphological characte-
ristics of brain tumors causing seizures [J]. Arch Neurol,
2010, 67(3): 336-342.
[2] Ruda R, Trevisan E, Soffietti R. Epilepsy and brain tumors
[J]. Curr Opin Oncol, 2010, 22(6): 611-620.
[3] Yang P, Liang T, Zhang C, et al. Clinicopathological factors
predictive of postoperative seizures in patients with gliomas
[J]. Seizure, 2016, 35(93-99.
[4] 崔向丽,陈 宝,林 松,等. 幕上胶质瘤伴继发癫痫 64
例临床分析[J]. 国际神经病学神经外科学杂志,2013,40
(3):223-225.
[5] Liubinas SV, D’Abaco GM, Moffat BM, et al. IDH1 mutation
is associated with seizures and protoplasmic subtype in
patients with low-grade gliomas [J]. Epilepsia, 2014, 55(9):
1438-1443.
[6] Yuan Y, Xiang W, Yanhui L, et al. Ki-67 overexpression in
WHO grade Ⅱ gliomas is associated with poor postopera-
tive seizure control [J]. Seizure, 2013, 22(10): 877-881.
[7] Whittle IR, Beaumont A. Seizures in patients with supraten-
torial oligodendroglial tumours: clinicopathological features
and management considerations [J]. Acta Neurochir (Wien),
1995, 135(1-2): 19-24.
[8] Rosati A, Tomassini A, Pollo B, et al. Epilepsy in cerebral
glioma: timing of appearance and histological correlations
[J]. J Neurooncol, 2009, 93(3): 395-400.
[9] Stang A. Critical evaluation of the Newcastle-Ottawa scale
for the assessment of the quality of nonrandomized studies
in meta-analyses [J]. Eur J Epidemiol, 2010, 25: 603-605.
[10] Wang Y, Qian T, You G, et al. Localizing seizure-suscept-
ible brain regions associated with low-grade gliomas using
voxel-based lesion-symptom mapping [J]. Neuro Oncol,
2015, 17(2): 282-288.
[11] Yuen TI, Morokoff AP, Bjorksten A, et al. Glutamate is
associated with a higher risk of seizures in patients with
gliomas [J]. Neurology, 2012, 79(9): 883-889.
[12] Hwang SL, Lin CL, Lee KS, et al. Factors influencing sei-
zures in adult patients with supratentorial astrocytic tumors
[J]. Acta Neurochir (Wien), 2004, 146(6): 589-594.
[13] Yang P, You G, Zhang W, et al. Correlation of preoperative
seizures with clinicopathological factors and prognosis in
anaplastic gliomas: a report of 198 patients from China [J].
Seizure, 2014, 23(10): 844-851.
[14] Chang EF, Potts MB, Keles GE, et al. Seizure characteristics
and control following resection in 332 patients with low-
grade gliomas [J]. J Neurosurg, 2008, 108(2): 227-235.
[15] Iuchi T, Hasegawa Y, Kawasaki K, et al. Epilepsy in patients
with gliomas: incidence and control of seizures [J]. J Clin
Neurosci, 2015, 22(1): 87-91.
[16] Pallud J, Audureau E, Blonski M, et al. Epileptic seizures in
diffuse low-grade gliomas in adults [J]. Brain, 2014, 137(Pt
2): 449-462.
[17] You G, Sha ZY, Yan W, et al. Seizure characteristics and
outcomes in 508 Chinese adult patients undergoing primary
resection of low-grade gliomas: a clinicopathological study
[J]. Neuro Oncol, 2012, 14(2): 230-241.
[18] Stockhammer F, Misch M, Helms HJ, et al. IDH1/2 muta-
tions in WHO grade Ⅱ astrocytomas associated with locali-
zation and seizure as the initial symptom [J]. Seizure, 2012,
21(3): 194-197.
[19] Mirsattari SM, Chong JJ, Hammond RR, et al. Do epileptic
seizures predict outcome in patients with oligodendroglioma
[J]. Epilepsy Res, 2011, 94(1-2): 39-44.
[20] Hwang SL, Lieu AS, Kuo TH, et al. Preoperative and post-
operative seizures in patients with astrocytic tumours:
analysis of incidence and influencing factors [J]. J Clin
Neurosci, 2001, 8(5): 426-429.
[21] Huang C, Li H, Chen M, et al. Factors associated with
preoperative and postoperative epileptic seizure in patients
with cerebral ganglioglioma [J]. Pak J Med Sci, 2014, 30(2):
245-249.
[22] Huang L, You G, Jiang T, et al. Correlation between tumor-
related seizures and molecular genetic profile in 103
Chinese patients with low-grade gliomas: a preliminary
study [J]. J Neurol Sci, 2011, 302(1-2): 63-67.
[23] 董 辉,周 桥,江 涛,等. 低级别胶质瘤复发再次术后
癫痫预后危险因素分析[J]. 中国临床神经外科杂志,
2016,21(9): 513-516.
[24] 刘长青,陈 凯,栾国明,等. 颅内节细胞胶质瘤所致癫痫
的手术预后相关因素分析[J]. 中国临床神经外科杂志,
2014,19(5):260-262.
相似文献/References:
[1]常英男 王 策 赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛 克 陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许 耿 路俊锋 杨 忠 施建斌 吴秋月 王 烨 庄冬晓 吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(05):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰 陈银生 赛 克 张湘衡 柯 超 杨群英 牟永告 许海雄 陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(05):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波 杨宇焦 张 逵 范润金 张 渊 杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性
癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(05):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚 成于思 王 辉 汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞
增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(05):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林 雨 张 恺 李 帅 杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明 徐成仕 王泽芬 曹长军 李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(05):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生 田道锋 张申起 陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(05):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯 驰 郭双毅 程龙海 罗 杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(05):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]